Eventide Healthcare & Life Sciences Fund CLASS I SHARES (ETIHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
31.47
+0.52 (1.68%)
May 19, 2025, 8:05 AM EDT
ETIHX Holdings List
As of Dec 31, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRNA | Verona Pharma plc | 4.41% |
2 | SRRK | Scholar Rock Holding Corporation | 3.97% |
3 | MIRM | Mirum Pharmaceuticals, Inc. | 3.73% |
4 | n/a | US BANK MMDA - USBGFS 9 | 3.68% |
5 | INSM | Insmed Incorporated | 3.60% |
6 | GH | Guardant Health, Inc. | 3.43% |
7 | BPMC | Blueprint Medicines Corporation | 2.93% |
8 | COLL | Collegium Pharmaceutical, Inc. | 2.85% |
9 | CLDX | Celldex Therapeutics, Inc. | 2.65% |
10 | AURA | Aura Biosciences, Inc. | 2.59% |
11 | SRPT | Sarepta Therapeutics, Inc. | 2.56% |
12 | AXSM | Axsome Therapeutics, Inc. | 2.53% |
13 | EXAS | Exact Sciences Corporation | 2.46% |
14 | NARI | Inari Medical Inc - INARI MEDICAL IN | 2.44% |
15 | PCVX | Vaxcyte, Inc. | 2.43% |
16 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.41% |
17 | VCYT | Veracyte, Inc. | 2.07% |
18 | FGUXX | First American Government Obligations Fund | 1.97% |
19 | GERN | Geron Corporation | 1.93% |
20 | IRTC | iRhythm Technologies, Inc. | 1.90% |
21 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.87% |
22 | UTHR | United Therapeutics Corporation | 1.85% |
23 | INSP | Inspire Medical Systems, Inc. | 1.79% |
24 | TGTX | TG Therapeutics, Inc. | 1.67% |
25 | BHVN | Biohaven Ltd. | 1.62% |
26 | EVH | Evolent Health, Inc. | 1.55% |
27 | IDYA | IDEAYA Biosciences, Inc. | 1.53% |
28 | KYMR | Kymera Therapeutics, Inc. | 1.42% |
29 | VKTX | Viking Therapeutics, Inc. | 1.38% |
30 | ARGX | argenx SE | 1.34% |
31 | RGEN | Repligen Corporation | 1.32% |
32 | CELC | Celcuity Inc. | 1.28% |
33 | RVMD | Revolution Medicines, Inc. | 1.26% |
34 | ACAD | ACADIA Pharmaceuticals Inc. | 1.21% |
35 | SNDX | Syndax Pharmaceuticals, Inc. | 1.20% |
36 | ARDX | Ardelyx, Inc. | 1.18% |
37 | KRYS | Krystal Biotech, Inc. | 1.16% |
38 | n/a | Avalyn Pharma | 1.16% |
39 | BBIO | BridgeBio Pharma, Inc. | 1.13% |
40 | PRVA | Privia Health Group, Inc. | 1.11% |
41 | n/a | SHORELINE BIOSCIENCES B | 1.08% |
42 | TMDX | TransMedics Group, Inc. | 1.03% |
43 | CYTK | Cytokinetics, Incorporated | 0.92% |
44 | RLAY | Relay Therapeutics, Inc. | 0.85% |
45 | RNA | Avidity Biosciences, Inc. | 0.84% |
46 | PRCT | PROCEPT BioRobotics Corporation | 0.78% |
47 | RCKT | Rocket Pharmaceuticals, Inc. | 0.75% |
48 | DVAX | Dynavax Technologies Corporation | 0.66% |
49 | ZNTL | Zentalis Pharmaceuticals, Inc. | 0.66% |
50 | LXEO | Lexeo Therapeutics, Inc. | 0.63% |
51 | n/a | Kestra Medical Tech | 0.62% |
52 | DYN | Dyne Therapeutics, Inc. | 0.60% |
53 | QTRX | Quanterix Corporation | 0.51% |
54 | n/a | BETA BIONIC SERIES B | 0.49% |
55 | NKTR | Nektar Therapeutics | 0.48% |
56 | INZY | Inozyme Pharma, Inc. | 0.48% |
57 | KROS | Keros Therapeutics, Inc. | 0.46% |
58 | BETABB2 | GOLDFINCH BIO B2 - BETA BIONICS B2 | 0.43% |
59 | ANNX | Annexon, Inc. | 0.40% |
60 | KRRO | Korro Bio, Inc. | 0.35% |
61 | SLN | Silence Therapeutics plc | 0.34% |
62 | FIGXX | Fidelity Government Portfolio | 0.27% |
63 | n/a | Beta Bionics Series D - BETA BIONICS INC SERIES D | 0.26% |
64 | BETABIC | Beta Bionics Inc | 0.25% |
65 | n/a | CASMA THERAPEUTICS II - FLARE THERAPEUTICS | 0.18% |
66 | n/a | Beta Bionics Inc. Ser E | 0.17% |
67 | n/a | Beta Bionics Series D - BETA BIONICS CL D WARRANT | 0.17% |
68 | n/a | PELOTON THERAPEUTICS - PELOTON THERAPEU | 0.12% |
69 | FRNOMD | FREENOME HOLDINGS, INC. - Freenome Holdings | 0.12% |
70 | n/a | FLARE THERAPEUTICS INC - FLARE THERAPEUTI | 0.10% |
71 | n/a | FLARE THERAPEUTICS INCORPORATED - Flare Series A Tranche 2 | 0.08% |
72 | n/a | BETA BIONICS INC SERIES C | 0.06% |
73 | n/a | PROMETHEUS BIOSCIENCES - EVIDA BIOSCIENCES INC | 0.05% |
74 | n/a | CASMA THERAPEUTICS - CASMA THERAPEUTI | 0.04% |
75 | n/a | CASMA THERAPEUTICS - CASMA SER B2 | 0.04% |
76 | n/a | Kojin Therapeutics | 0.04% |
77 | KojinA1 | KOJIN THERAPEUTICS INC | 0.04% |
78 | n/a | BIOSPLICE THERAPEUTICS INC. SERIES C - BISPL F 03/12/2025 | 0.03% |
79 | n/a | CASMA THERAPEUTICS II | 0.02% |
80 | n/a | Freenome | 0.02% |
81 | n/a | CASMA THERAPEUTICS, INC. - CASMA THERAPEUTICS | 0.01% |
82 | n/a | BIOSPLICE THERAPEUTICS INC. - Biosplice Therapeutics | 0.00% |
83 | GOLDFB2 | GOLDFINCH BIO B2 | 0.00% |
84 | n/a | BioSplice Therapeutics | 0.00% |
85 | n/a | GOLDFINCH BIOPHARMA INC B | 0.00% |
86 | n/a | GOLDFINCH BIOPHARMA INC | 0.00% |
As of Dec 31, 2024